These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 72833

  • 1. The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis.
    Scardino PT, Cox HD, Waldmann TA, Mcintire KR, Mittemeyer B, Javadpour N.
    J Urol; 1977 Dec; 118(6):994-9. PubMed ID: 72833
    [No Abstract] [Full Text] [Related]

  • 2. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.
    Lange PH, McIntire KR, Waldmann TA, Hakala TR, Fraley EE.
    N Engl J Med; 1976 Nov 25; 295(22):1237-40. PubMed ID: 62281
    [No Abstract] [Full Text] [Related]

  • 3. Current concepts in management of testicular tumor.
    Javadpour N.
    Urol Surv; 1978 Jun 25; 28(3):89-94. PubMed ID: 80873
    [No Abstract] [Full Text] [Related]

  • 4. Serum markers in testicular tumors.
    Narayana AS, Loening S, Weimar G, Culp DA.
    J Urol; 1979 Jan 25; 121(1):51-3. PubMed ID: 83396
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of stage I, II testicular tumor based on tumor markers].
    Kamidono S, Arakawa S, Hamami G, Umezu K, Fujii A, Ishigami J.
    Nihon Hinyokika Gakkai Zasshi; 1983 Aug 25; 74(8):1383-93. PubMed ID: 6202917
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Re: alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Javadpour N.
    J Urol; 1978 Mar 25; 119(3):422-3. PubMed ID: 76688
    [No Abstract] [Full Text] [Related]

  • 9. [Significance of measurement of serum levels of tumor markers with germinal cell testicular tumor--value of beta-subunit human chorionic gonadotropin and alpha-fetoprotein (author's transl)].
    Kamidono S, Arakawa S, Masuda M, Hamami G, Shimatani N, Itho N, Nakatsuka E, Fujii A, Ohono S, Ishigami J, Yoshimoto Y, Hattori M, Fujita T, Okada S.
    Nihon Hinyokika Gakkai Zasshi; 1980 Apr 25; 71(4):352-62. PubMed ID: 6157042
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Testicular cancer: role of biological tumor markers.
    Pearson JC, Spaulding JT, Friedman MA.
    Cancer Treat Rev; 1979 Dec 25; 6(4):217-21. PubMed ID: 93978
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of seminoma.
    Horwich A, Dearnaley DP.
    Semin Oncol; 1992 Apr 25; 19(2):171-80. PubMed ID: 1372759
    [No Abstract] [Full Text] [Related]

  • 14. The value of alpha-fetoprotein and beta-human chorionic gonadotrophin in the management of testicular tumours.
    Narayana AS, Loening S, Culp DA.
    Br J Urol; 1978 Dec 25; 50(7):605-8. PubMed ID: 88986
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ, Zborzil J, Sikorowa L, Leńko J, Kamińska JA, Gadek A.
    Oncology; 1983 Dec 25; 40(1):1-10. PubMed ID: 6185897
    [Abstract] [Full Text] [Related]

  • 16. Tumour markers in testicular tumours.
    Chisholm GD.
    Prog Clin Biol Res; 1985 Dec 25; 203():81-91. PubMed ID: 2421346
    [No Abstract] [Full Text] [Related]

  • 17. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH.
    Natl Cancer Inst Monogr; 1978 Dec 25; (49):215-7. PubMed ID: 86163
    [Abstract] [Full Text] [Related]

  • 18. [Pregnancy-specific beta 1-glycoprotein: a tumor marker].
    Horne CH, Bremner RD.
    Ric Clin Lab; 1984 Dec 25; 14 Suppl 2():33-8. PubMed ID: 6085182
    [No Abstract] [Full Text] [Related]

  • 19. [Beta-HCG positive seminoma--incidence with special reference to tumor marker concentration in testicular venous blood].
    Mumperow E, Kressel K, Hartmann M.
    Urologe A; 1991 Mar 25; 30(2):114-6; discussion 117. PubMed ID: 1711727
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.